| Released | Contributor | Author | Title | Pages | Price |
| 1-Dec-2009 | New Constructs, LLC |
N/A
| DCGN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 30-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| deCODE genetics | 5 |
$25 |
| 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 30-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | DECODE GENETICS INC (DCGN=US) 2-weeks forecast | 1 |
$10 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: DECODE GENETICS -- DCGN | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ALXN , ANSV , DCGN , HGSI , IDRA -- DRUGS | 3 |
$4 |
| 24-Nov-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of DECODE GENETICS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 14-Nov-2009 | Standard & Poor's Factual Report |
N/A
| deCODE genetics | 7 |
$35 |
0.90% Nasdaq 
Research Reports
